USPTO serial 79099130
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Perry
David M. Perry Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103-6998| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants for non-medical purposes; enzymes for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; nucleic acids; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; microbial chemicals used in environmental monitoring | SECTION 71 - CANCELLED | — |
| 005 | pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders | SECTION 71 - CANCELLED | — |
| 010 | surgical and medical apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 28, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 28, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 18, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 16, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 16, 2019 | INPC | INVALIDATION PROCESSED | — |
| Sep 4, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 4, 2019 | C71T | CANCELLED SECTION 71 | — |
| May 29, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 10, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 16, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 25, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 15, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 30, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 30, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 29, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 29, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 13, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 13, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 22, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 22, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 8, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 7, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 17, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 17, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 7, 2011 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 20, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 19, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 19, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 17, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |